Gabelli & Co Investment Advisers’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-23,487
Closed -$237K 542
2021
Q2
$237K Buy
+23,487
New +$237K 0.03% 316